SERB Pharmaceuticals Employee Directory
Pharmaceutical ManufacturingÎle-de-France, France501-1000 Employees
SERB Pharmaceuticals is a mid-sized pharmaceutical manufacturer based in Paris, Île-de-France. The company focuses on rare diseases and urgent medical needs, delivering medicines for conditions where timely delivery and reliability are critical. By blending biotech agility with the scale and processes of global pharma, it operates end-to-end across more than 100 countries to bring at least 70 essential medicines to patients and clinicians when they are needed. In May 2026, SERB announced the commercial launch of ThyroSafe 130 mg potassium iodide tablets in the United States. It also disclosed an agreement to acquire exclusive development and commercialisation rights to Idefirix (imlifidase) for the European Union, United Kingdom, Switzerland, Norway, Liechtenstein, Iceland and the Middle East and North Africa region from Hansa Biopharma.